Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 1231 AL 1245

Differences in performance in CAMCOG-R domains between old and oldest old patients with Alzheimer's disease

Canneti B, Mosqueira AJ, Carreras T, Gago-Veiga AB, Onsurbe C, Ruiz M, Vivancos J.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 Jul;25(4):588-597. doi: 10.1080/13825585.2017.1353679. Epub 2017 Jul 13.

Targeting Fyn Kinase in Alzheimer's Disease

Nygaard HB.

Biol Psychiatry. 2018 Feb 15;83(4):369-376. doi: 10.1016/j.biopsych.2017.06.004. Epub 2017 Jun 13.

Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease

Maurano STP, da Silva DJ, Ávila MP, Magacho L.

Int Ophthalmol. 2018 Oct;38(5):1839-1844. doi: 10.1007/s10792-017-0658-4. Epub 2017 Jul 25.

BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease

Prati F, Bottegoni G, Bolognesi ML, Cavalli A.

J Med Chem. 2018 Feb 8;61(3):619-637. doi: 10.1021/acs.jmedchem.7b00393. Epub 2017 Aug 8.

Stress induced neural reorganization: A conceptual framework linking depression and Alzheimer's disease

Ross JA, Gliebus G, Van Bockstaele EJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jul 13;85:136-151. doi: 10.1016/j.pnpbp.2017.08.004. Epub 2017 Aug 10.

mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia

Di Domenico F, Tramutola A, Foppoli C, Head E, Perluigi M, Butterfield DA.

Free Radic Biol Med. 2018 Jan;114:94-101. doi: 10.1016/j.freeradbiomed.2017.08.009. Epub 2017 Aug 12.

Alzheimer's disease as oligomeropathy

Ono K.

Neurochem Int. 2018 Oct;119:57-70. doi: 10.1016/j.neuint.2017.08.010. Epub 2017 Aug 16.

Three-Dimensional Models of the Human Brain Development and Diseases

Jorfi M, D'Avanzo C, Kim DY, Irimia D.

Adv Healthc Mater. 2018 Jan;7(1):10.1002/adhm.201700723. doi: 10.1002/adhm.201700723. Epub 2017 Aug 28.

Targeting NAD(+) degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty

Ruan Q, Ruan J, Zhang W, Qian F, Yu Z.

Pharmacol Res. 2018 Feb;128:345-358. doi: 10.1016/j.phrs.2017.08.010. Epub 2017 Aug 25.

Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease

Theendakara V, Peters-Libeu CA, Bredesen DE, Rao RV.

Mol Neurobiol. 2018 Jun;55(6):5243-5254. doi: 10.1007/s12035-017-0757-2. Epub 2017 Sep 6.

Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer's Disease

Voytyuk I, De Strooper B, Chávez-Gutiérrez L.

Biol Psychiatry. 2018 Feb 15;83(4):320-327. doi: 10.1016/j.biopsych.2017.08.001. Epub 2017 Aug 10.

Conceptual elaboration versus direct lexical access in WAIS-similarities: differential effects of white-matter lesions and gray matter volumes

Fernaeus SE, Hellström Å.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 Nov;25(6):893-903. doi: 10.1080/13825585.2017.1378310. Epub 2017 Sep 18.

Therapeutic peptides for CNS indications: Progress and challenges

Morimoto BH.

Bioorg Med Chem. 2018 Jun 1;26(10):2859-2862. doi: 10.1016/j.bmc.2017.09.011. Epub 2017 Sep 9.

Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis

Bloom GS, Lazo JS, Norambuena A.

Neuropharmacology. 2018 Jul 1;136(Pt B):192-195. doi: 10.1016/j.neuropharm.2017.09.016. Epub 2017 Sep 29.

Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise

van Dyck CH.

Biol Psychiatry. 2018 Feb 15;83(4):311-319. doi: 10.1016/j.biopsych.2017.08.010. Epub 2017 Aug 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias